Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 3
2005 2
2006 1
2007 1
2008 2
2010 1
2011 1
2012 2
2013 2
2014 1
2015 1
2016 1
2018 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
The Difficulty With Implementing a Policy on Surgical Attire.
Guglielmi CL, DiTullio BL, Kirchner BA, Halverson A, Beers RA, Everson C, Hohenberger H, Groah L. Guglielmi CL, et al. Among authors: beers ra. AORN J. 2016 Mar;103(3):319-28. doi: 10.1016/j.aorn.2016.01.010. AORN J. 2016. PMID: 26924370 No abstract available.
Remifentanil update: clinical science and utility.
Beers R, Camporesi E. Beers R, et al. CNS Drugs. 2004;18(15):1085-104. doi: 10.2165/00023210-200418150-00004. CNS Drugs. 2004. PMID: 15581380 Review.
Domain II of Pseudomonas Exotoxin Is Critical for Efficacy of Bolus Doses in a Xenograft Model of Acute Lymphoblastic Leukemia.
Müller F, Cunningham T, Beers R, Bera TK, Wayne AS, Pastan I. Müller F, et al. Among authors: beers r. Toxins (Basel). 2018 May 21;10(5):210. doi: 10.3390/toxins10050210. Toxins (Basel). 2018. PMID: 29883379 Free PMC article.
Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors.
Mazor R, Zhang J, Xiang L, Addissie S, Awuah P, Beers R, Hassan R, Pastan I. Mazor R, et al. Among authors: beers r. Mol Cancer Ther. 2015 Dec;14(12):2789-96. doi: 10.1158/1535-7163.MCT-15-0532. Epub 2015 Oct 6. Mol Cancer Ther. 2015. PMID: 26443804 Free PMC article.
Recombinant immunotoxins in the treatment of cancer.
Pastan I, Beers R, Bera TK. Pastan I, et al. Among authors: beers r. Methods Mol Biol. 2004;248:503-18. doi: 10.1385/1-59259-666-5:503. Methods Mol Biol. 2004. PMID: 14970517 No abstract available.
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes.
Mazor R, Eberle JA, Hu X, Vassall AN, Onda M, Beers R, Lee EC, Kreitman RJ, Lee B, Baker D, King C, Hassan R, Benhar I, Pastan I. Mazor R, et al. Among authors: beers r. Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8571-6. doi: 10.1073/pnas.1405153111. Epub 2014 May 5. Proc Natl Acad Sci U S A. 2014. PMID: 24799704 Free PMC article.
Medication injection safety knowledge and practices among anesthesiologists: New York State, 2011.
Gounder P, Beers R, Bornschlegel K, Hinterland K, Balter S. Gounder P, et al. Among authors: beers r. J Clin Anesth. 2013 Nov;25(7):521-8. doi: 10.1016/j.jclinane.2013.04.013. Epub 2013 Sep 2. J Clin Anesth. 2013. PMID: 24008193
Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes.
Onda M, Beers R, Xiang L, Lee B, Weldon JE, Kreitman RJ, Pastan I. Onda M, et al. Among authors: beers r. Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5742-7. doi: 10.1073/pnas.1102746108. Epub 2011 Mar 21. Proc Natl Acad Sci U S A. 2011. PMID: 21436054 Free PMC article.
Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin A.
Mazor R, Vassall AN, Eberle JA, Beers R, Weldon JE, Venzon DJ, Tsang KY, Benhar I, Pastan I. Mazor R, et al. Among authors: beers r. Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):E3597-603. doi: 10.1073/pnas.1218138109. Epub 2012 Dec 3. Proc Natl Acad Sci U S A. 2012. PMID: 23213206 Free PMC article.
A recombinant immunotoxin against the tumor-associated antigen mesothelin reengineered for high activity, low off-target toxicity, and reduced antigenicity.
Weldon JE, Xiang L, Zhang J, Beers R, Walker DA, Onda M, Hassan R, Pastan I. Weldon JE, et al. Among authors: beers r. Mol Cancer Ther. 2013 Jan;12(1):48-57. doi: 10.1158/1535-7163.MCT-12-0336. Epub 2012 Nov 6. Mol Cancer Ther. 2013. PMID: 23136186 Free PMC article.
20 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback